摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3-Quinolin-4-yl-prop-2-ynyl)-carbamic acid tert-butyl ester | 872215-08-2

中文名称
——
中文别名
——
英文名称
(3-Quinolin-4-yl-prop-2-ynyl)-carbamic acid tert-butyl ester
英文别名
Tert-butyl (3-(quinolin-4-yl)prop-2-yn-1-yl)carbamate;tert-butyl N-(3-quinolin-4-ylprop-2-ynyl)carbamate
(3-Quinolin-4-yl-prop-2-ynyl)-carbamic acid tert-butyl ester化学式
CAS
872215-08-2
化学式
C17H18N2O2
mdl
——
分子量
282.342
InChiKey
QGERRCDPNACHHN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.11
  • 重原子数:
    21.0
  • 可旋转键数:
    1.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    51.22
  • 氢给体数:
    1.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    描述:
    (3-Quinolin-4-yl-prop-2-ynyl)-carbamic acid tert-butyl ester 在 palladium on activated charcoal 氢气 作用下, 以 乙醇乙酸乙酯 为溶剂, 反应 1.0h, 生成 (3-Quinolin-4-yl-propyl)-carbamic acid tert-butyl ester
    参考文献:
    名称:
    A new type of ketolide bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether: Synthesis and structure–activity relationships (2)
    摘要:
    A new type of ketolide bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether and its analogues were prepared, and their antibacterial activities and pharmacokinetic properties were evaluated. We found that the introduction of all (R)-alkyl group between the amide and iminoether groups could improve the pharmacokinetic properties while maintaining the activity against erythromycin-resistant Streptococcus pneumoniae. Among the ketolides prepared with the (R)-alkyl group, compound 5p with an N-(3-quinoxalin-6-yl-propyl)-propionamide moiety was found to have in vivo efficacy comparable to CAM with potent in vitro antibacterial activities against the key respiratory pathogens including Haemophilus influenzae and erythromycin-resistant S. pneumoniae. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2006.01.036
  • 作为产物:
    描述:
    4-碘代喹啉N-Boc-氨基丙炔 在 bis-triphenylphosphine-palladium(II) chloride copper(l) iodide三乙胺 作用下, 以 乙腈 为溶剂, 反应 2.0h, 生成 (3-Quinolin-4-yl-prop-2-ynyl)-carbamic acid tert-butyl ester
    参考文献:
    名称:
    A new type of ketolide bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether: Synthesis and structure–activity relationships (2)
    摘要:
    A new type of ketolide bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether and its analogues were prepared, and their antibacterial activities and pharmacokinetic properties were evaluated. We found that the introduction of all (R)-alkyl group between the amide and iminoether groups could improve the pharmacokinetic properties while maintaining the activity against erythromycin-resistant Streptococcus pneumoniae. Among the ketolides prepared with the (R)-alkyl group, compound 5p with an N-(3-quinoxalin-6-yl-propyl)-propionamide moiety was found to have in vivo efficacy comparable to CAM with potent in vitro antibacterial activities against the key respiratory pathogens including Haemophilus influenzae and erythromycin-resistant S. pneumoniae. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2006.01.036
点击查看最新优质反应信息

文献信息

  • A new type of ketolides bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether synthesis and structure–activity relationships
    作者:Takashi Nomura、Tsutomu Iwaki、Tatsuro Yasukata、Koichi Nishi、Yukitoshi Narukawa、Koichi Uotani、Toshihiko Hori、Hideaki Miwa
    DOI:10.1016/j.bmc.2005.07.041
    日期:2005.12
    A new type of ketolides, bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether and a cyclic carbonate at the G 11, 12 position was prepared and the antibacterial activities of the compounds were evaluated. Some of the derivatives showed potent antibacterial activity against both Haemophilus influenzae and Streptococcus pneumoniae, which are clinically important respiratory tract pathogens. Among the derivatives prepared, compound 5s with a quinolin-4-yl moiety was found to have potent and well-balanced activity against S. pneumoniae and H. influenzae including erythromycin-resistant strains. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多